PC

Peter Clayton

Scientific Advisor at Lumos Pharma

Dr. Clayton has been a Professor of Child Health and Paediatric Endocrinology at the University of Manchester since 2001. He has authored 200 publications on the clinical and basic science aspects of pediatric endocrinology and has served on the editorial boards of many endocrine journals ( Hormone Research in Paediatrics, European Journal of Endocrinology and Clinical Endocrinology). Clayton has been a member of the Councils of the Growth Hormone Research Society, the Society for Endocrinology UK, and the European Society of Paediatric Endocrinology, being Chair of the ESPE Corporate Liaison Board. He has led international endocrine committees and organizations with his latest position as of 2018 serving as chair of the International Consortium of Pediatric Endocrinology (ICPE). Having initially obtained a first-class degree in Physiology & Pharmacology in 1981, he graduated from Manchester University Medical School in 1984 (Distinction in Paediatrics) and defended his thesis “Growth Patterns after Neuroaxis Irradiation in Childhood”. After spending some time at the University of Virginia, USA as a MRC Travelling Fellow in 1990-1991 with work primarily directed at molecular endocrinology in the laboratory, he returned to Manchester to establish a research group of both clinicians and scientists, working under the broad remit of investigating normal and abnormal growth from clinical, biochemical and molecular perspectives. He took up a Senior Lectureship in Child Health in 1994 and was promoted to Professor of Child Health and Paediatric Endocrinology in 2001. He was the lead for the Division of Human Development in the Manchester Medical School from 2001-2007 and was Director of the Institute of Human Development in the Faculty of Medical & Human Sciences from 2014-2016.

Links

Timeline

  • Scientific Advisor

    Current role